Loading…
Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling
Cannabinoids (CBs) are neuroprotective in vivo and in vitro, but the mechanisms of their actions are unknown. The aim of this study was to elucidate the signaling pathways that mediate the protective effect of CBs on primary cultured neurons. The neurotoxin S-AMPA induced significant death of rat pr...
Saved in:
Published in: | Molecular and cellular neuroscience 2005, Vol.28 (1), p.189-194 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133 |
---|---|
cites | cdi_FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133 |
container_end_page | 194 |
container_issue | 1 |
container_start_page | 189 |
container_title | Molecular and cellular neuroscience |
container_volume | 28 |
creator | Molina-Holgado, Francisco Pinteaux, Emmanuel Heenan, Laura Moore, Jonathan D. Rothwell, Nancy J. Gibson, Rosemary M. |
description | Cannabinoids (CBs) are neuroprotective in vivo and in vitro, but the mechanisms of their actions are unknown. The aim of this study was to elucidate the signaling pathways that mediate the protective effect of CBs on primary cultured neurons. The neurotoxin S-AMPA induced significant death of rat primary cortical neurons, which was inhibited by the CB agonist HU-210. Antagonists selective for CB
1 or CB
2 receptors (AM 281 or AM 630, respectively) reversed the neuroprotective effect of HU-210 on S-AMPA-induced cell death. HU-210 triggered activation of AKT, but not activation of the ERK1/2, JNK or p38 signaling pathways. The phosphatidylinositol 3-kinase (PI 3-K) inhibitors LY294002 and wortmannin prevented phosphorylation of AKT in response to HU-210, and reversed the neuroprotective effect of HU-210 on S-AMPA-induced excitotoxicity. Thus the PI 3-K/AKT signaling pathway mediates the neuroprotective effect of exogenous cannabinoids such as HU-210 in primary CNS neurons. |
doi_str_mv | 10.1016/j.mcn.2004.09.004 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17529444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1044743104002179</els_id><sourcerecordid>17529444</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133</originalsourceid><addsrcrecordid>eNp9UcFuEzEUXCEQLYUP4IJ84rbb57V3nRWnqgKKqODSni3Hfm4cNnawnUr5Dn6Yt0okbpxmpDdvpJlpmvccOg58vN52Oxu7HkB2MHUEL5pLDtPQTqJXLxcuZauk4BfNm1K2ADD0k3jdXPBhBDUN4rL58wMPOe1zqmhreEaG3hMrLHlWN8jKMRLUYJk1MZp1iCk4dvfY9hxYiGyfw87kI7Mpk8jMLC5-sTCTke3QBVPRsfWR7Tep7DemBnecyaSEmmYm2l8hmoLXN98fWAlP0dDt6W3zypu54LszXjWPXz4_3N619z-_fru9uW-tWPW1tc4gGOLSKKe4QOGVFxbsavCAQo0gYVjS8BEmidxNHPveSeVHs-q5EFfNx5Mvxf99wFL1LhSL82wipkPRXFFdUkoS8pPQ5lRKRq_PsTUHvSyht5qW0MsSGiZNQD8fzuaHNfXw7-NcPQk-nQRIEZ8DZl1swGips0wLaJfCf-z_Anh5nBY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17529444</pqid></control><display><type>article</type><title>Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling</title><source>ScienceDirect Freedom Collection</source><creator>Molina-Holgado, Francisco ; Pinteaux, Emmanuel ; Heenan, Laura ; Moore, Jonathan D. ; Rothwell, Nancy J. ; Gibson, Rosemary M.</creator><creatorcontrib>Molina-Holgado, Francisco ; Pinteaux, Emmanuel ; Heenan, Laura ; Moore, Jonathan D. ; Rothwell, Nancy J. ; Gibson, Rosemary M.</creatorcontrib><description>Cannabinoids (CBs) are neuroprotective in vivo and in vitro, but the mechanisms of their actions are unknown. The aim of this study was to elucidate the signaling pathways that mediate the protective effect of CBs on primary cultured neurons. The neurotoxin S-AMPA induced significant death of rat primary cortical neurons, which was inhibited by the CB agonist HU-210. Antagonists selective for CB
1 or CB
2 receptors (AM 281 or AM 630, respectively) reversed the neuroprotective effect of HU-210 on S-AMPA-induced cell death. HU-210 triggered activation of AKT, but not activation of the ERK1/2, JNK or p38 signaling pathways. The phosphatidylinositol 3-kinase (PI 3-K) inhibitors LY294002 and wortmannin prevented phosphorylation of AKT in response to HU-210, and reversed the neuroprotective effect of HU-210 on S-AMPA-induced excitotoxicity. Thus the PI 3-K/AKT signaling pathway mediates the neuroprotective effect of exogenous cannabinoids such as HU-210 in primary CNS neurons.</description><identifier>ISSN: 1044-7431</identifier><identifier>EISSN: 1095-9327</identifier><identifier>DOI: 10.1016/j.mcn.2004.09.004</identifier><identifier>PMID: 15607953</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Cannabinoids - pharmacology ; Cells, Cultured ; Cerebral Cortex - cytology ; Cerebral Cortex - drug effects ; Cerebral Cortex - metabolism ; Dronabinol - analogs & derivatives ; Dronabinol - pharmacology ; Enzyme Inhibitors - pharmacology ; Excitatory Amino Acid Agonists - pharmacology ; Nerve Degeneration - chemically induced ; Nerve Degeneration - drug therapy ; Nerve Degeneration - prevention & control ; Neurons - drug effects ; Neurons - metabolism ; Neuroprotective Agents - pharmacology ; Neurotoxins - antagonists & inhibitors ; Phosphatidylinositol 3-Kinases - drug effects ; Phosphatidylinositol 3-Kinases - metabolism ; Protein Serine-Threonine Kinases - drug effects ; Protein Serine-Threonine Kinases - metabolism ; Proto-Oncogene Proteins - drug effects ; Proto-Oncogene Proteins - metabolism ; Proto-Oncogene Proteins c-akt ; Rats ; Rats, Sprague-Dawley ; Receptor, Cannabinoid, CB1 - antagonists & inhibitors ; Receptor, Cannabinoid, CB1 - metabolism ; Receptor, Cannabinoid, CB2 - antagonists & inhibitors ; Receptor, Cannabinoid, CB2 - metabolism ; Signal Transduction - drug effects ; Signal Transduction - physiology</subject><ispartof>Molecular and cellular neuroscience, 2005, Vol.28 (1), p.189-194</ispartof><rights>2004 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133</citedby><cites>FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15607953$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Molina-Holgado, Francisco</creatorcontrib><creatorcontrib>Pinteaux, Emmanuel</creatorcontrib><creatorcontrib>Heenan, Laura</creatorcontrib><creatorcontrib>Moore, Jonathan D.</creatorcontrib><creatorcontrib>Rothwell, Nancy J.</creatorcontrib><creatorcontrib>Gibson, Rosemary M.</creatorcontrib><title>Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling</title><title>Molecular and cellular neuroscience</title><addtitle>Mol Cell Neurosci</addtitle><description>Cannabinoids (CBs) are neuroprotective in vivo and in vitro, but the mechanisms of their actions are unknown. The aim of this study was to elucidate the signaling pathways that mediate the protective effect of CBs on primary cultured neurons. The neurotoxin S-AMPA induced significant death of rat primary cortical neurons, which was inhibited by the CB agonist HU-210. Antagonists selective for CB
1 or CB
2 receptors (AM 281 or AM 630, respectively) reversed the neuroprotective effect of HU-210 on S-AMPA-induced cell death. HU-210 triggered activation of AKT, but not activation of the ERK1/2, JNK or p38 signaling pathways. The phosphatidylinositol 3-kinase (PI 3-K) inhibitors LY294002 and wortmannin prevented phosphorylation of AKT in response to HU-210, and reversed the neuroprotective effect of HU-210 on S-AMPA-induced excitotoxicity. Thus the PI 3-K/AKT signaling pathway mediates the neuroprotective effect of exogenous cannabinoids such as HU-210 in primary CNS neurons.</description><subject>Animals</subject><subject>Cannabinoids - pharmacology</subject><subject>Cells, Cultured</subject><subject>Cerebral Cortex - cytology</subject><subject>Cerebral Cortex - drug effects</subject><subject>Cerebral Cortex - metabolism</subject><subject>Dronabinol - analogs & derivatives</subject><subject>Dronabinol - pharmacology</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Excitatory Amino Acid Agonists - pharmacology</subject><subject>Nerve Degeneration - chemically induced</subject><subject>Nerve Degeneration - drug therapy</subject><subject>Nerve Degeneration - prevention & control</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>Neurotoxins - antagonists & inhibitors</subject><subject>Phosphatidylinositol 3-Kinases - drug effects</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>Protein Serine-Threonine Kinases - drug effects</subject><subject>Protein Serine-Threonine Kinases - metabolism</subject><subject>Proto-Oncogene Proteins - drug effects</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Proto-Oncogene Proteins c-akt</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptor, Cannabinoid, CB1 - antagonists & inhibitors</subject><subject>Receptor, Cannabinoid, CB1 - metabolism</subject><subject>Receptor, Cannabinoid, CB2 - antagonists & inhibitors</subject><subject>Receptor, Cannabinoid, CB2 - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - physiology</subject><issn>1044-7431</issn><issn>1095-9327</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9UcFuEzEUXCEQLYUP4IJ84rbb57V3nRWnqgKKqODSni3Hfm4cNnawnUr5Dn6Yt0okbpxmpDdvpJlpmvccOg58vN52Oxu7HkB2MHUEL5pLDtPQTqJXLxcuZauk4BfNm1K2ADD0k3jdXPBhBDUN4rL58wMPOe1zqmhreEaG3hMrLHlWN8jKMRLUYJk1MZp1iCk4dvfY9hxYiGyfw87kI7Mpk8jMLC5-sTCTke3QBVPRsfWR7Tep7DemBnecyaSEmmYm2l8hmoLXN98fWAlP0dDt6W3zypu54LszXjWPXz4_3N619z-_fru9uW-tWPW1tc4gGOLSKKe4QOGVFxbsavCAQo0gYVjS8BEmidxNHPveSeVHs-q5EFfNx5Mvxf99wFL1LhSL82wipkPRXFFdUkoS8pPQ5lRKRq_PsTUHvSyht5qW0MsSGiZNQD8fzuaHNfXw7-NcPQk-nQRIEZ8DZl1swGips0wLaJfCf-z_Anh5nBY</recordid><startdate>2005</startdate><enddate>2005</enddate><creator>Molina-Holgado, Francisco</creator><creator>Pinteaux, Emmanuel</creator><creator>Heenan, Laura</creator><creator>Moore, Jonathan D.</creator><creator>Rothwell, Nancy J.</creator><creator>Gibson, Rosemary M.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>2005</creationdate><title>Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling</title><author>Molina-Holgado, Francisco ; Pinteaux, Emmanuel ; Heenan, Laura ; Moore, Jonathan D. ; Rothwell, Nancy J. ; Gibson, Rosemary M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Cannabinoids - pharmacology</topic><topic>Cells, Cultured</topic><topic>Cerebral Cortex - cytology</topic><topic>Cerebral Cortex - drug effects</topic><topic>Cerebral Cortex - metabolism</topic><topic>Dronabinol - analogs & derivatives</topic><topic>Dronabinol - pharmacology</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Excitatory Amino Acid Agonists - pharmacology</topic><topic>Nerve Degeneration - chemically induced</topic><topic>Nerve Degeneration - drug therapy</topic><topic>Nerve Degeneration - prevention & control</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>Neurotoxins - antagonists & inhibitors</topic><topic>Phosphatidylinositol 3-Kinases - drug effects</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>Protein Serine-Threonine Kinases - drug effects</topic><topic>Protein Serine-Threonine Kinases - metabolism</topic><topic>Proto-Oncogene Proteins - drug effects</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Proto-Oncogene Proteins c-akt</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptor, Cannabinoid, CB1 - antagonists & inhibitors</topic><topic>Receptor, Cannabinoid, CB1 - metabolism</topic><topic>Receptor, Cannabinoid, CB2 - antagonists & inhibitors</topic><topic>Receptor, Cannabinoid, CB2 - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Molina-Holgado, Francisco</creatorcontrib><creatorcontrib>Pinteaux, Emmanuel</creatorcontrib><creatorcontrib>Heenan, Laura</creatorcontrib><creatorcontrib>Moore, Jonathan D.</creatorcontrib><creatorcontrib>Rothwell, Nancy J.</creatorcontrib><creatorcontrib>Gibson, Rosemary M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Molecular and cellular neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Molina-Holgado, Francisco</au><au>Pinteaux, Emmanuel</au><au>Heenan, Laura</au><au>Moore, Jonathan D.</au><au>Rothwell, Nancy J.</au><au>Gibson, Rosemary M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling</atitle><jtitle>Molecular and cellular neuroscience</jtitle><addtitle>Mol Cell Neurosci</addtitle><date>2005</date><risdate>2005</risdate><volume>28</volume><issue>1</issue><spage>189</spage><epage>194</epage><pages>189-194</pages><issn>1044-7431</issn><eissn>1095-9327</eissn><abstract>Cannabinoids (CBs) are neuroprotective in vivo and in vitro, but the mechanisms of their actions are unknown. The aim of this study was to elucidate the signaling pathways that mediate the protective effect of CBs on primary cultured neurons. The neurotoxin S-AMPA induced significant death of rat primary cortical neurons, which was inhibited by the CB agonist HU-210. Antagonists selective for CB
1 or CB
2 receptors (AM 281 or AM 630, respectively) reversed the neuroprotective effect of HU-210 on S-AMPA-induced cell death. HU-210 triggered activation of AKT, but not activation of the ERK1/2, JNK or p38 signaling pathways. The phosphatidylinositol 3-kinase (PI 3-K) inhibitors LY294002 and wortmannin prevented phosphorylation of AKT in response to HU-210, and reversed the neuroprotective effect of HU-210 on S-AMPA-induced excitotoxicity. Thus the PI 3-K/AKT signaling pathway mediates the neuroprotective effect of exogenous cannabinoids such as HU-210 in primary CNS neurons.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15607953</pmid><doi>10.1016/j.mcn.2004.09.004</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1044-7431 |
ispartof | Molecular and cellular neuroscience, 2005, Vol.28 (1), p.189-194 |
issn | 1044-7431 1095-9327 |
language | eng |
recordid | cdi_proquest_miscellaneous_17529444 |
source | ScienceDirect Freedom Collection |
subjects | Animals Cannabinoids - pharmacology Cells, Cultured Cerebral Cortex - cytology Cerebral Cortex - drug effects Cerebral Cortex - metabolism Dronabinol - analogs & derivatives Dronabinol - pharmacology Enzyme Inhibitors - pharmacology Excitatory Amino Acid Agonists - pharmacology Nerve Degeneration - chemically induced Nerve Degeneration - drug therapy Nerve Degeneration - prevention & control Neurons - drug effects Neurons - metabolism Neuroprotective Agents - pharmacology Neurotoxins - antagonists & inhibitors Phosphatidylinositol 3-Kinases - drug effects Phosphatidylinositol 3-Kinases - metabolism Protein Serine-Threonine Kinases - drug effects Protein Serine-Threonine Kinases - metabolism Proto-Oncogene Proteins - drug effects Proto-Oncogene Proteins - metabolism Proto-Oncogene Proteins c-akt Rats Rats, Sprague-Dawley Receptor, Cannabinoid, CB1 - antagonists & inhibitors Receptor, Cannabinoid, CB1 - metabolism Receptor, Cannabinoid, CB2 - antagonists & inhibitors Receptor, Cannabinoid, CB2 - metabolism Signal Transduction - drug effects Signal Transduction - physiology |
title | Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A28%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroprotective%20effects%20of%20the%20synthetic%20cannabinoid%20HU-210%20in%20primary%20cortical%20neurons%20are%20mediated%20by%20phosphatidylinositol%203-kinase/AKT%20signaling&rft.jtitle=Molecular%20and%20cellular%20neuroscience&rft.au=Molina-Holgado,%20Francisco&rft.date=2005&rft.volume=28&rft.issue=1&rft.spage=189&rft.epage=194&rft.pages=189-194&rft.issn=1044-7431&rft.eissn=1095-9327&rft_id=info:doi/10.1016/j.mcn.2004.09.004&rft_dat=%3Cproquest_cross%3E17529444%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c382t-cdae0ac384a7d713e3f7f3c0c85f0e3760405ffec16094e1d91e22d47f6a82133%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17529444&rft_id=info:pmid/15607953&rfr_iscdi=true |